Investor Relations

Latest News and Press Releases

October 9, 2024

Inspira™️ Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism

September 24, 2024

Inspira™ Launches INSPIRA™ ART100 at the World’s Largest Extracorporeal Life Support Conference

September 13, 2024

Inspira™ Secures a Second U.S. Patent Approval for Orbiting Blood Oxygenation Delivery System

August 28, 2024

Inspira™ to Publish HYLA™ Clinical Results in Fourth Quarter 2024

For a one-on-one update on Inspira’s activities

Schedule a meeting with Joe Hayon, President and Co-founder

SEC Filings

Research Coverage

Firm
Analyst
E-mail
Aegis Capital
Nathan Weinstein, CFA
nweinstein@aegiscap.com
Hunter Diamond, CFA
research@diamondequityresearch.com

Inspira Technologies is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Inspira Technologies’ performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Inspira Technologies or its management. Inspira Technologies does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Get in Touch!

    Ha-Tidhar St 2, Ra'anana, Israel

    I consent to receive emails from Inspira Technologies Oxy B.H.N LTD. To request removal from the mailing list at any time, please send an email to info@inspirao2.com. You can find out about your rights and privacy choices, and how we use your information in our Privacy Policy.

    Join Our Newsletter!

    Sign up and be the first to get notified on new updates of Inspira Technologies

      Copyright © 2018-2022 Inspira-Technologies OXY B.H.N. LTD., All rights reserved